Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Cancer Metastasis Rev. 2014 Sep;33(0):581–594. doi: 10.1007/s10555-013-9475-z

Table 4.

Selected ongoing clinical trials of drugs targeting Hedgehog signaling in prostate cancer, adapted from clinicaltrials.gov

Target Agent Phase Summary Identifier
Smoothened (SMO) Itraconazole II Single-arm efficacy study;
Itraconazole in docetaxel-refractory metastatic CRPC
NCT01450683
Smoothened (SMO) Itraconazole II Single-arm efficacy study;
Itraconazole in PSA-recurrent/non-metastatic prostate cancer
NCT01787331